mai welcomes dietary supplement manufacturer “DOD Biotech” on June 20

Stocks News Wednesday June 20, 2018 08:48 —PRESS RELEASE LOCAL

Bangkok--20 Jun--SET Market for Alternative Investment (mai) will list DOD Biotech pcl, a dietary supplement manufacturer, on June 20, under the ticker symbol "DOD". The company has a market capitalization at its initial public offering (IPO) of THB 3.81 billion (approx. USD 119 million). mai President Prapan Charoenprawatt said that DOD would list and start trading on mai in the Consumer Products industry group. DOD manufactures dietary supplement products mainly made from natural extracted substances, with one-stop services for customers ranging from consultation services for production, marketing and distribution channels, research and development of product formula to suit customer needs, food serial number registration with the Thai Food and Drug Administration (Thai FDA), to product and packaging design. With its own manufacturing plant that meets international quality and safety standards, DOD mainly produces Original Design Manufacturer (ODM) products for customers, while manufacturing its own brand of dietary supplement products named "Dai a to". DOD has a paid-up registered capital of THB 205 million, consisting of 300 million existing common shares and 110 million newly issued shares, with a par value of THB 0.50 each. The entire newly issued shares were offered to general public via IPO at THB 9.30 each, for a total of THB 1.02 billion, during June 12-14, 2018. Advisory Plus Co., Ltd. is its financial advisor and KT Zmico Securities Co., Ltd. is the lead underwriter. DOD Managing Director Supamas Isarabhakdi said that the company focused on research and development, teaming up with academics from both public and private sectors to create new manufacturing formula and developing products to keep pace with demand in line with dietary supplement market trend. The fund raised would be used to invest in an ingredient extraction plant and international standard research laboratory, develop new brands, for loan repayment, and as working capital. DOD's three major shareholders after the IPO are Pattanaprathet Group (68.15 percent), Rianpricha Group (2.28 percent) and Boontarika Chueachot (1.89 percent). The IPO price was determined based on a book building process, equivalent to price-to-earnings (P/E) ratio of 17.22 times calculated by using the company's net profit amounting to THB 219.87 million in the past 12 months (April 1, 2017 - March 31, 2018) divided by fully diluted shares, representing earnings per share of THB 0.54. DOD's dividend policy is to pay no less than 50 percent of net profit after corporate income tax and legal reserves. For more information, please see the company's prospectus at the Securities and Exchange Commission's website at www.sec.or.th; and for general information, please visit www.dodbiotech.com, as well as www.set.or.th.

เว็บไซต์นี้มีการใช้งานคุกกี้ ศึกษารายละเอียดเพิ่มเติมได้ที่ นโยบายความเป็นส่วนตัว และ ข้อตกลงการใช้บริการ รับทราบ